Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 44/75 ]
NASDAQ | Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment.
The company was incorporated in 2016 and is headquartered in Menlo Park, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 10, 25 | 0.91 | 0.16 Increased by +468.75% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 83.52 M Increased by +117.40% | 1.51 M Increased by +110.11% | Increased by +1.80% Increased by +104.65% |
| Jun 30, 25 | 66.57 M Increased by +84.11% | -246.00 K Increased by +92.59% | Decreased by -0.37% Increased by +95.97% |
| Mar 31, 25 | 58.96 M Increased by +79.07% | -3.99 M Increased by +66.40% | Decreased by -6.76% Increased by +81.24% |
| Dec 31, 24 | 45.08 M - | -11.48 M - | Decreased by -25.46% - |
| Sep 30, 24 | 38.42 M - | -14.90 M - | Decreased by -38.79% - |
| Jun 30, 24 | 36.16 M - | -3.32 M - | Decreased by -9.18% - |
| Mar 31, 24 | 32.93 M - | -11.87 M - | Decreased by -36.05% - |